Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures [Phase 3]

View source ↗

Summary

This document notes a Phase 3 double-blind, randomized trial evaluating the efficacy and safety of Vormatrigine in adults with focal epilepsy. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vormatrigine (Vormatrigine)

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Focal Epilepsy | Phase 3 | Status: RECRUITING